SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.
SQZ Biotech has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in March 2022.
SQZ Biotech's investors include Temasek, Alumni Ventures, Illumina Ventures, National Science Foundation, Polaris Partners.
SQZ Biotech is headquartered in Watertown, United States.
SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.
SQZ Biotech is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SQZ Biotech — Funding & Investors." VCBacked, March 21, 2022, https://www.vcbacked.co/company/sqz-biotech. Accessed November 13, 2026.
VCBacked. (2022). SQZ Biotech — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/sqz-biotech
{{cite web |title=SQZ Biotech — Funding & Investors |url=https://www.vcbacked.co/company/sqz-biotech |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at SQZ Biotech? Request a listing update